Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A pilot cross-sectional study of non-communicable diseases in TB household contacts.
Hamada Y, Lugendo A, Ntshiqa T, Kubeka G, Lalashowi JM, Mwastaula S, Ntshamane K, Sabi I, Wilson S, Copas A, Velen K, Ntinginya NE, Minja LT, Abubakar I, Charalambous S, Rangaka MX. Hamada Y, et al. Among authors: rangaka mx. IJTLD Open. 2024 Apr 1;1(4):154-159. doi: 10.5588/ijtldopen.23.0579. eCollection 2024 Apr. IJTLD Open. 2024. PMID: 38988408 Free PMC article.
C-Tb: a latent tuberculosis skin test for the 21st century?
Abubakar I, Jackson C, Rangaka MX. Abubakar I, et al. Among authors: rangaka mx. Lancet Respir Med. 2017 Apr;5(4):236-237. doi: 10.1016/S2213-2600(17)30012-7. Epub 2017 Feb 1. Lancet Respir Med. 2017. PMID: 28159607 No abstract available.
Eliminating tuberculosis in low-burden countries.
Jackson C, Cohen T, Rangaka MX, Abubakar I. Jackson C, et al. Among authors: rangaka mx. Int J Tuberc Lung Dis. 2018 Jan 1;22(1):3. doi: 10.5588/ijtld.17.0707. Int J Tuberc Lung Dis. 2018. PMID: 29297418 No abstract available.
Update in Tuberculosis and Nontuberculous Mycobacteria 2017.
Abubakar I, Gupta RK, Rangaka MX, Lipman M. Abubakar I, et al. Among authors: rangaka mx. Am J Respir Crit Care Med. 2018 May 15;197(10):1248-1253. doi: 10.1164/rccm.201801-0106UP. Am J Respir Crit Care Med. 2018. PMID: 29537298 No abstract available.
Discovery and validation of a personalized risk predictor for incident tuberculosis in low transmission settings.
Gupta RK, Calderwood CJ, Yavlinsky A, Krutikov M, Quartagno M, Aichelburg MC, Altet N, Diel R, Dobler CC, Dominguez J, Doyle JS, Erkens C, Geis S, Haldar P, Hauri AM, Hermansen T, Johnston JC, Lange C, Lange B, van Leth F, Muñoz L, Roder C, Romanowski K, Roth D, Sester M, Sloot R, Sotgiu G, Woltmann G, Yoshiyama T, Zellweger JP, Zenner D, Aldridge RW, Copas A, Rangaka MX, Lipman M, Noursadeghi M, Abubakar I. Gupta RK, et al. Among authors: rangaka mx. Nat Med. 2020 Dec;26(12):1941-1949. doi: 10.1038/s41591-020-1076-0. Epub 2020 Oct 19. Nat Med. 2020. PMID: 33077958 Free PMC article.
An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study.
Surey J, Stagg HR, Yates TA, Lipman M, White PJ, Charlett A, Muñoz L, Gosce L, Rangaka MX, Francis M, Hack V, Kunst H, Abubakar I. Surey J, et al. Among authors: rangaka mx. BMC Infect Dis. 2021 Jan 21;21(1):90. doi: 10.1186/s12879-021-05766-9. BMC Infect Dis. 2021. PMID: 33478428 Free PMC article. Clinical Trial.
96 results